Copying biotech medicine attracts more drugmakers (Reuters)

Reuters - More drugmakers are seeing potential in the business of producing copycat versions of expensive biotechnology drugs as U.S. guidelines take shape.

Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20110113/hl_nm/us_healthcare_biosimilars

mesothelioma treatment options mesothelioma lung cancer mesothelioma survival rate